EUVIMEDEUVIMED entdecken
Validierungsstudie

Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort

Zhensheng Hu, Cong Lai, Hongze Liu, Jianping Man, Kai Chen, Qian Ouyang, Yi Zhou

Breast Cancer · 2024-11 · 31 (6) · 1046-1058

DOI: 10.1007/s12282-024-01619-w ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Breast Cancer, online erschienen am 19.07.2024. Verfasst von Zhensheng Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, 510080, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, MicroRNAs, Early Detection of Cancer. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, the Key Research and Development Program of China, the Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: The study focuses on enhancing breast cancer (BC) prognosis through early detection, aiming to establish a non-invasive, clinically viable BC screening method using specific serum miRNA levels. METHODS: Involving 11,349 participants across BC, 11 other cancer types, and control groups, the study identified serum biomarkers through feature selection and developed two BC screening models using six machine learning algorithms. These models underwent evaluation across test, internal, and external validation sets, assessing performance metrics like accuracy, sensitivity, specificity, and the area under the curve (AUC). Subgroup analysis was conducted to test model stability. RESULTS: Based on the three serum miRNA biomarkers (miR-1307-3p, miR-5100, and miR-4745-5p), a BC screening model, SM4BC3miR model, was developed. This model achieved AUC performances of 0.986, 0.986, and 0.939 on the test, internal, and external sets, respectively. Furthermore, the SSM4BC model, utilizing ratio scores of miR-1307-3p/miR-5100 and miR-4745-5p/miR-5100, showed AUCs of 0.973, 0.980, and 0.953, respectively. Subgroup analyses underscored both models' robustness and stability. CONCLUSION: This research introduced the SM4BC3miR and SSM4BC models, leveraging three specific serum miRNA biomarkers for breast cancer screening. Demonstrating high accuracy and stability, these models present a promising approach for early detection of breast cancer. However, their practical application and effectiveness in clinical settings remain to be further validated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorMicroRNAsEarly Detection of CancerHumansFemaleMiddle AgedMachine LearningAdultAgedArea Under CurvePrognosisCohort StudiesSensitivity and Specificity

Stichwörter der Autor:innen

Breast cancerMachine learningScreening modelSerum miRNA

Substanzen

Biomarkers, TumorMicroRNAs

Autor:innen und Institutionen

  • Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, 510080, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Breast Surgery, Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Yinfeng Road No. 33, HaiZhu District, Guangzhou, 510260, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. ouyq26@mail.sysu.edu.cn.
  • Department of Breast Surgery, Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Yinfeng Road No. 33, HaiZhu District, Guangzhou, 510260, China. ouyq26@mail.sysu.edu.cn.
  • Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, 74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, 510080, China. zhouyi@mail.sysu.edu.cn.

Förderung

  • Natural Science Foundation of Guangdong Province
  • the Key Research and Development Program of China
  • the Natural Science Foundation of Guangdong Province
  • the Guangzhou Science and Technology Plan

Zitieren

APA

Hu, Z., Lai, C., Liu, H., Man, J., Chen, K., Ouyang, Q., & Zhou, Y. (2024). Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort. Breast Cancer, 31(6), 1046-1058. https://doi.org/10.1007/s12282-024-01619-w

Vancouver

Hu Z, Lai C, Liu H, Man J, Chen K, Ouyang Q, et al. Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort. Breast Cancer. 2024;31(6):1046-1058. doi:10.1007/s12282-024-01619-w

BibTeX
@article{Hu2024,
  author = {Hu, Zhensheng and Lai, Cong and Liu, Hongze and Man, Jianping and Chen, Kai and Ouyang, Qian and Zhou, Yi},
  title = {Identification and validation of screening models for breast cancer with 3 serum miRNAs in an 11,349 samples mixed cohort},
  journal = {Breast Cancer},
  year = {2024},
  volume = {31},
  number = {6},
  pages = {1046--1058},
  doi = {10.1007/s12282-024-01619-w}
}
Kostenlos starten →